• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Ovarian Epithelial Cancer

Ovarian Epithelial Cancer - 24 Studies Found

Terminated : Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer
: Epithelial Ovarian Cancer
: 2009-04-27
: Drug: Intraperitoneal (IP) Cisplatin For patients who have had neoadjuvant chemotherapy followed by opti
Not yet recruiting : A Study to Examine Olaparib Maintenance Retreatment in Patients With Epithelial Ovarian Cancer.
: Epithelial Ovarian Cancer
: 2017-03-24
:
  • Drug: Active Comparator: Olaparib tablets

Completed : Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer
: Epithelial Ovarian Cancer
: 2007-06-21
:
  • Drug: gemcitabine
  • Drug: carboplatin

Completed : Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer
: Recurrent Ovarian Epithelial Cancer
: 1999-12-10
:
  • Biological: ALVAC-hB7.1 Given

<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.